Heart monitors for horses, shaded pens for bulls part of rodeo safety at Calgary Stampede
After scorching heat at the rodeo last summer, Ed Pajor, a professor of animal behaviour and welfare in the University of Calgary's faculty of veterinary medicine, says the animals could use a break.
"We saw things like increased respiration rate in some of the bulls. We saw some bulls drooling. These are signs that the animals might be experiencing some discomfort due to the heat," Pajor said at a news conference Tuesday.
The university is working with the Stampede to study some of the animals this year. They'll specifically look at whether bucking bulls and broncos will be happier and healthier if they have a shady place to hang out right before the competition.
"It seems like a pretty straightforward question," said Pajor, adding if shade is beneficial, the Stampede would have to decide whether to invest in more tent coverings in the future.
Additional research at the rodeo is to focus on the heart health of horses in the chuckwagon races.
Dr. Renaud Léguillette, with the university's veterinary school, specializes in equine health and performance, and works closely with chuckwagon horses during the Stampede.
His research includes identifying in equine blood a baseline for troponin — a protein released when the heart muscle is damaged — to track underlying cardiovascular or other health issues.
"The goal of our research is to prevent cardiac accidents during the chuckwagon racing due to a cardiac problem," said Léguillette.
"There are some horses who have more electrical activity issues when they race or have a harder time to recover from the races."
At the Stampede, outrider horses and horses pulling the wagons are to be fitted with electrocardiograms before and during the races.
Léguillette said the devices and the blood tests can show what horses are at a higher risk of cardiac arrest and that information is passed on to chuckwagon drivers.
"I call it like a green light, an orange light and a red light. The red light horses, I will definitely have a discussion with the drivers ... they are very responsive, concerned and will make the right decisions."
An official with the Stampede said research in this area could benefit an entire industry.
"We know there is an element of risk in all sport. Our goal is to create the safest conditions possible. That's why all of this research takes place ... to remove all of those elements of risk," said Kristina Barnes, the Stampede's director of agriculture and western events.
"Can we remove completely that element of risk? No. But anything that we can control we certainly will."
The 10-day celebration of western culture, which runs from July 4 to 13, has long been a target of animal rights groups. The Vancouver Humane Society wants the rodeo portion of the Stampede eliminated.
"We're seeing deaths at the Calgary Stampede almost every single year. It's really not a matter of if another animal will die at the Stampede ... it's when," said Chantelle Archambault with the group.
"Last year, there were four animal deaths. It also marks at least 109 animal deaths at the Stampede since we began tracking fatalities in 1986."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Is cereal good or bad for you? 11 best 'healthy' brands in Canada, ranked on sugar, fibre, protein and more
A dietitian says that regardless of healthiness, it's necessary to start your day by fuelling your body with food. If in the mad-dash morning rush you're managing to put any food in your stomach at all, registered dietitian Janine LaForte wants you to know you're doing all right. She knows breakfast is a challenge for those facing the consequences of the snooze button or racing against the arrival of the school bus. This stress, LaForte says, is particularly felt for families facing food insecurity, an interlocking barrier mounting up on top of regular morning hurley-burley. LaForte, who also owns Real Life Nutrition in Winnipeg, notes her personal ideal morning meal isn't breakfast cereal: 'It would be something like just an oatmeal, right? There's that one ingredient [and] you add in what you'd like.' This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle. However, she notes that cereal is an affordable, dependable choice to start the day for many: 'There are a lot of families who are struggling. And there's a lot of kids who don't want to eat breakfast. And cereal — and I will tell you, from my own personal experience — has been the go-to breakfast because it's quick. Kids are often rushing in the morning, and parents [are] as well.' Cereal, she says, is typically an easy, quick meal. 'If it's a matter of eating a bowl of cereal, even if it's something that you may deem not so 'healthy,' it's at least something that they're getting in before they go out the door. Or even as an adult goes out the door.' But with some cereals so laden with sugar that they border on candy, how can you make sure you're pouring yourself a bowl of goodness in those snatched A.M. moments? Here, LaForte guides us through what makes some cereals stack up better than others. Plus, keep scrolling for a nutritional comparison of some of the most popular 'healthy' cereal brands you can find in Canadian grocery stores. Fibre, sugar, balance: What to look for when shopping for cereal 'I think breakfast is a really good opportunity to get fibre in your diet,' LaForte says, adding that choosing higher-fibre cereal is an excellent starting point for a nutritious breakfast. Whole grains, of course, pack more fibre than their refined counterparts, so LaForte suggests checking ingredient lists to ensure what your cereal is made of. A 2015 study (the most recent stats available) from the American Journal of Clinical Nutrition shares LaForte's focus on fibre. It indicates that less than 25 per cent of Canadians age 19 and older get enough of the digestion-and-satiety-aiding nutrient daily. Making a bowl of cereal into a balanced meal with staying power also means topping the cereal with things like fruit, seeds, nuts or yogurt, LaForte adds. Think classic options like sliced bananas and blueberries, or even pumpkin seeds and Greek yogurt. She also adds that variety is the key to good nutrition, so switching up the toppings and the cereals themselves — say, trying one made from corn and then one made from wheat — helps ensure you're getting different nutrients into your overall diet. Then there's sugar, an ingredient LaForte says 'people tend to eat more [of] than they need to.' Comparing nutritional labels and going for the lower-sugar option is an effective method to make sure you're pouring a healthier bowl of cereal. But LaForte does note that since cereals are 'fortified with vitamins and minerals in Canada,' the sugary treats could be a source of nutrients for picky eaters and those facing food insecurity. While reducing added sugar where you can in your diet is an important part of healthy eating, so is ensuring that you're getting enough of key nutrients. Are popular 'healthy' cereal brands in Canada actually healthy? In the breakdown below, we've rounded up a variety of healthy cereals to see which ones are your best A.M. bet in terms of nutritional information per a one-cup serving — not including milk. It's worth mentioning that all of the cereals are sources of nutrients like potassium, calcium and iron, with a majority also having several vitamins. It turns out that Shredded Wheat is tough to beat with no sugar and a mere gram of fat alongside a high fibre and protein content. Müslix, meanwhile, packs more sugar and fat than you might expect. Fibre One, on the other hand, lives up to its name with a whopping 27 grams of fibre — just five grams less than an average adult woman needs daily. Shredded Wheat Original Calories: 180 Fat: 1 g Fibre: 6 g Sugar: 0 g Sodium: 0 g Protein: 5 g Fibre One Crunchy Original Calories: 140 Fat: 1 g Fibre: 27 g Sugar: 1 g Sodium: 220 mg Protein: 4 g Multi Grain Cheerios Calories: 120 Fat: 1 g Fibre: 2 g Sugar: 6 g Sodium: 160 mg Protein: 2 g Kellogg's Two Scoops Raisin Bran Calories: 180 Fat: 1 g Fibre: 7 g Sugar: 14 g Sodium: 170 mg Protein: 5 g Nature's Path Smart Bran Calories: 140 Fat: 2 g Fibre: 23 g Sugar: 11 g Sodium: 230 mg Protein: 5 g Nature's Path Multigrain Flakes Calories: 210 Fat: 2 g Fibre: 10 g Sugar: 8 g Sodium: 210 mg Protein: 6 g Kellogg's All-Bran Original Calories: 180 Fat: 3 g Fibre: 18 g Sugar: 10 g Sodium: 320 mg Protein: 8 g Kellogg's Vector Maple Flavour Calories: 160 Fat: 1 g Fibre: 3 g Sugar: 12 g Sodium: 160 mg Protein: 10 g Kashi GoActive Mixed Berry Crunch Calories: 290 Fat: 4.5 g Fibre: 14 g Sugar: 15 g Sodium: 85 mg Protein: 14 g Kashi GoActive Honey Almond Flax Crunch Calories: 300 Fat: 8 g Fibre: 15 g Sugar: 17 g Sodium: 230 mg Protein: 15 g Kellogg's Müslix Almond Raisin Calories: 240 Fat: 2.5 g Fibre: 7 g Sugar: 17 g Sodium: 150 mg Protein: 6 g In the end, no matter if you're eating Shredded Wheat or Coco Puffs, LaForte touts the importance of starting your day with breakfast: 'Food is the fuel for our bodies. If you want to be able to function and do your best during your day, you need to fuel your brain. 'Some people don't like eating breakfast. However, if you can get something in, anything — a yogurt, some fruit, a balanced breakfast is the best. But if you can just get something in within an hour of waking up, that's going to be the best for your body.'
Yahoo
5 hours ago
- Yahoo
Sask. enforcing mandatory CWD and bovine TB testing in select zones for upcoming hunting season
White-tailed deer, mule deer and elk now must be tested in several wildlife management zones (WMZs) in Saskatchewan during the upcoming hunting season. The mandatory tests are to detect cases of chronic wasting disease (CWD), as well as bovine tuberculosis (TB), which many are concerned could be transmitted through game animals. Darrell Crabbe is the executive director of the Sask. Wildlife Federation. His organization has been calling for mandatory testing since 2019. "The mandatory testing for CWD and these other areas are as much for an expansion of an agricultural process than it is about the science," Crabbe said. "It happens to provide us some good information on prevalence in some zones that historically haven't had any." The province said mandatory CWD testing will be conducted in WMZs 43, 47, 50 and 55. On top of that, in response to confirmed cases in two separate cattle herds in 2023 and 2024, mandatory bovine tuberculosis testing will take place in WMZs 37 and 39. You can see what WMZ an area falls under using the province's interactive map. "Historically we didn't have a whole bunch of information in those zones that they're talking about here, so it'll be good to have some of that data to work with," Crabbe said. "We firmly believe that hunters should always be at the front of the line to assist with citizen science to try to rectify any of these types of conditions we have to deal with." In a statement released on Monday, Environment Minister Travis Keisig said monitoring wildlife health protects the hunting and agriculture economies. "We rely on hunters to submit samples for testing, and we appreciate their co-operation and thank them for their continued support," Keisig said. According to the 2023-24 CWD Surveillance Program, Saskatchewan had some of the highest rates of the disease in North America. Hunters harvesting any deer or elk in those zones will have to submit the animals' heads for testing within one month of death or by Jan. 21, 2026, whichever comes first. The provincial government and the Sask. Wildlife Federation encourage hunters to voluntarily submit samples in all zones outside of those with mandatory testing, to get a better sense of the spread. Drop-off locations will be available throughout the province and testing is free. The Ministry of Environment said it will also be adding more bins for the safe disposal of carcasses or meat from CWD positive animals.
Yahoo
6 hours ago
- Yahoo
PharmaTher Founder and CEO Issues Letter to Shareholders Following the FDA Approval of Ketamine (KETARx(TM))
Toronto, Ontario--(Newsfile Corp. - August 14, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today that Fabio Chianelli, the Company's Founder, Chairman and Chief Executive Officer, has issued the following letter to shareholders. Dear Fellow Shareholders, Earlier this year, I wrote to you about the challenges we faced with our FDA Priority Original Abbreviated New Drug Application for our ketamine product, which we have named KETARx™. I was thrilled to receive the FDA approval letter on Friday, August 8, 2025, for KETARx™, for its use in surgical pain management (anesthesia and sedation). We proudly announced this milestone on Monday, August 11, 2025. This approval is more than just an achievement—it is a turning point. Our journey has been long, filled with determination, resilience, and belief in ketamine's transformative potential. Now, we have not just seen the light at the end of the tunnel—we've stepped into it. With this success, a new era begins for PharmaTher, and I believe the opportunities ahead could be game-changing for PharmaTher, our shareholders, and most importantly, the millions of patients in need. The Road Ahead - From Approval to Impact We are moving swiftly into pre-launch commercialization of KETARx™ in the U.S. while also preparing international regulatory filings. Bringing a drug to market requires handling of many moving parts—marketing, sales, manufacturing, and global cost-optimization strategies, just to name a few. While this complexity is expected, the immediate surge of interest from specialty pharmaceutical companies—ranging from large to mid-sized industry players to niche innovators—has been nothing short of exhilarating. Partnership discussions are already underway, but make no mistake—we are also advancing our commercial plan to launch KETARx™ this year. We have a clear and scalable sales channel targeting hospitals, specialty clinics, government institutions such as the U.S. Department of Defense and Veterans Health Administration, as well as clinical research programs and support for special or expanded access programs. And this is only Phase One. Millions of surgical patients stand to benefit today, but the long-term potential for KETARx™ across other indications is vast. Unlocking the Full Power of Ketamine Our FDA approval reinforces our mission: to unlock the full pharmaceutical potential of ketamine for mental health, neurological, and pain disorders. I am especially excited about our clinical-stage programs, which include: Parkinson's disease (treatment for levodopa-induced dyskinesia) Amyotrophic Lateral Sclerosis (ALS) Complex Regional Pain Syndrome (CRPS) A ketamine patch and wearable pump for diverse mental health and pain conditions These programs fall under the FDA's 505(b)(2) pathway, and with the current momentum in regulatory openness toward psychedelic-assisted therapies—plus potential fast-track opportunities—we believe the landscape for ketamine innovation is only improving. While our immediate focus remains on KETARx™ commercialization, our discussions with potential partners include these pipeline programs, which could significantly expand our market reach and value creation. From Vision to Reality When I founded PharmaTher in April 2020, our vision was clear: be all-in on ketamine. That conviction has carried us through the highs and lows to this moment—FDA approval of our first ketamine product. This milestone isn't just a win for us; it's a validation of ketamine's place as a transformative treatment option and a springboard into an entirely new chapter for the Company, unlocking an unprecedented array of opportunities that were once beyond our reach. We are standing at the threshold of what I believe will be a new era in medicine—one where ketamine's proven benefits can touch millions more lives worldwide. Our commitment is unwavering: to innovate, to grow, and to deliver on the promise of ketamine to transform global health outcomes. With your continued support, I believe we will build PharmaTher into a leader in next-generation ketamine therapeutics—creating meaningful impact for patients, expanding globally, and unlocking the full potential of ketamine. The opportunities ahead are vast, the timing is perfect, and our determination has never been stronger. PharmaTher is poised for an extraordinary next chapter. Sincerely, Fabio ChianelliFounder, Chairman and CEOPharmaTher Holdings Ltd. About PharmaTher Holdings Ltd. PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on unlocking the pharmaceutical potential of Ketamine (KETARx™) for mental health, neurological, and pain disorders. For more information, visit For more information about PharmaTher, please contact:Fabio ChianelliChief Executive OfficerPharmaTher Holdings 1-888-846-3171Email: info@ Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement This press release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words "closer", "could", "confident", "would", "intend", "expect", "believe", "will", "projected", "estimated", "potential", "promise", "strong", "aim", "may", "plan", "proposed", "lead", "toward", "anticipate", "provide", "position", "leverage", "mitigate", "before", "prior", and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on PharmaTher Holdings Ltd. (the "Company") current belief or assumptions as to the outcome and timing of such future events. Forward-looking information is based on reasonable assumptions that have been made by the Company at the date of the information and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements. The forward-looking information contained in this press release is made as of the date hereof, and Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The foregoing statements expressly qualify any forward-looking information contained herein. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in Company's management's discussion and analysis for the three and nine months ended February 28, 2025 dated April 24, 2025, which is available on the Company's profile at This news release does not constitute an offer to sell or the solicitation of an offer to buy, and shall not constitute an offer, solicitation or sale in any state, province, territory or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province, territory or jurisdiction. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data